FierceBiotech ١٨ فبراير ٢٠٢٦ Immunology CRO RoukenBio pens pact with AVS Bio for more predictable antibody development
FierceBiotech ١٧ فبراير ٢٠٢٦ Cell therapy company hopes to end Tokyo biotech IPO drought with $92M offering
FierceBiotech ١٧ فبراير ٢٠٢٦ Sanofi points to 'key opportunity' for Teva-partnered IBD in long-term data
FierceBiotech ١٧ فبراير ٢٠٢٦ Compass guides psychedelic therapy to 2nd pivotal depression win, triggering approval push
FierceBiotech ١٧ فبراير ٢٠٢٦ Novocure gets FDA nod for tumor-treating electric fields targeting pancreatic cancer
FierceBiotech ١٧ فبراير ٢٠٢٦ Gilead’s latest synthetic lethal therapy comes via $1.5B deal with China’s Genhouse
FierceBiotech ١٦ فبراير ٢٠٢٦ Biopharma funding to experience 'continued, albeit disciplined' recovery in 2026: PitchBook
FierceBiotech ١٤ فبراير ٢٠٢٦ 'It's really a dire time for patients': Biohaven CEO says FDA red tape is blocking access to rare disease treatments
FierceBiotech ١٣ فبراير ٢٠٢٦ With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment
FierceBiotech ١٣ فبراير ٢٠٢٦ FDA clears Encora Therapeutics’ wearable wrist device for essential tremor
FierceBiotech ١٣ فبراير ٢٠٢٦ After R&D head exits, Immunocore CEO pairs ambition with caution for growing cancer portfolio
FierceBiotech ١٣ فبراير ٢٠٢٦ Integra LifeSciences cuts roles as 65 staffers impacted from Princeton, N.J., site